Investigation Overview
July 21, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Imprivata Inc (NYSE:IMPR), was announced concerning whether the takeover of Imprivata Inc. by Thoma Bravo, LLC for $19.25 per share is unfair to NYSE:IMPR stockholders.
The investigation by a law firm concerns whether certain officers and directors of Imprivata Inc breached their fiduciary duties owed to NYSE:IMPR investors in connection with the proposed acquisition.
On July 13, 2016, Imprivata Inc (NYSE:IMPR) announced that it has entered into an agreement to be acquired by an affiliate of private equity investment firm Thoma Bravo, LLC. Under the terms of the agreement, shareholders of record of Imprivata Inc (NYSE:IMPR) will receive $19.25 in cash per share of Imprivata common stock.
However, the investigation concerns whether the offer is unfair to NYSE:IMPR stockholders. More specifically, the investigation concerns whether the Imprivata Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.